ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Goldline Pharmaceutical IPO vs Jivial Industries IPO

Comparison between Goldline Pharmaceutical IPO and Jivial Industries IPO.

IPO Details

Goldline Pharmaceutical IPO is a SME Fixed Price IPO proposed to list at BSE SME while Jivial Industries IPO is a SME Fixed Price proposed to list at BSE SME.

 Goldline Pharmaceutical IPOJivial Industries IPO
LogoGoldline Pharmaceutical IPO LogoJivial Industries IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingFixed Price
Listing AtBSE SMEBSE SME
Lead ManagersCumulative Capital Pvt.Ltd.Corporate Makers Capital Ltd.
RegistrarBigshare Services Pvt.Ltd.Bigshare Services Pvt.Ltd.
Market MakerNirman Share Brokers Pvt.Ltd.Sunflower Broking Pvt.Ltd.
DRHPDRHP DRHP
RHPRHP
Final ProspectusFinal Prospectus Final Prospectus
Anchor InvestorAnchor Investor
IPO Allotment URLIPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Goldline Pharmaceutical IPO is up to ₹11.02 Cr whereas the issue size of the Jivial Industries IPO is up to ₹30.39 Cr. The final issue price of Goldline Pharmaceutical IPO is ₹43.00 per share and of Jivial Industries IPO is ₹196.00 per share.

 Goldline Pharmaceutical IPOJivial Industries IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹41.00 per share
Issue Price (Upper)₹43.00 per share
Issue Price (Final)₹43.00 per share₹196.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size3000 shares600 shares
Fresh Issue Size25,62,000 shares12,78,000 shares
Fresh Issue Size (Amount)up to ₹11.02 Crup to ₹25.05 Cr
OFS Issue Size0 shares2,72,400 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹5.34 Cr
Issue Size Total25,62,000 shares15,50,400 shares
Issue Size Total (Amount)up to ₹11.02 Crup to ₹30.39 Cr

IPO Timetable

Goldline Pharmaceutical IPO opens on May 12, 2026, while Jivial Industries IPO opens on Jun 23, 2026. The closing date of Goldline Pharmaceutical IPO and Jivial Industries IPO is May 14, 2026, and Jun 25, 2026, respectively.

 Goldline Pharmaceutical IPOJivial Industries IPO
Anchor Bid DateMay 11, 2026
Issue OpenMay 12, 2026Jun 23, 2026
Issue CloseMay 14, 2026Jun 25, 2026
Basis Of Allotment (Tentative)May 15, 2026Jun 29, 2026
Initiation of Refunds (Tentative)May 18, 2026Jun 30, 2026
Credit of Share (Tentative)May 18, 2026Jun 30, 2026
Listing date (Tentative)May 19, 2026Jul 01, 2026
Anchor Lockin End date 1Jun 14, 2026
Anchor Lockin End date 2Aug 13, 2026

Financials & KPIs

Goldline Pharmaceutical IPO P/E ratio is 10.47, as compared to Jivial Industries IPO P/E ratio of 21.83.

 Goldline Pharmaceutical IPOJivial Industries IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 202531 Mar 202531 Mar 202431 Mar 2023
Assets27.4026.2822.9319.39
Total Income21.4128.0623.5719.85
Profit After Tax2.222.831.810.26
EBITDA4.165.834.302.19
NET Worth12.3610.357.865.89
Reserves and Surplus3.651.653.762.08
Total Borrowing9.4711.0311.1310.83
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Dec 202531 Mar 202531 Mar 202431 Mar 2023
Assets14.1110.256.942.16
Total Income12.2012.0711.068.40
Profit After Tax2.952.972.411.17
EBITDA3.763.753.081.42
NET Worth11.668.725.751.53
Reserves and Surplus8.355.412.441.52
Total Borrowing1.230.380.440.18
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)79.7094.53
Promoter Shareholding (Post-Issue)57.2961.16
P/E Ratio10.4721.83
Market Cap₹41.28 Cr.₹91.52 Cr.
ROE35.8341.09
ROCE38.4547.12
Debt/Equity1.500.04
EPS₹4.11₹8.98
RoNW27.3741.09

Shares Offered

In the Goldline Pharmaceutical IPO Retail Individual Investors (RII) are offered 9,00,000 shares while in Jivial Industries IPO retail investors are offered 9,00,000 shares. Qualified Institutional Buyers (QIB) are offered 5,40,000 shares in Goldline Pharmaceutical IPO and 0 shares in Jivial Industries IPO.

 Goldline Pharmaceutical IPOJivial Industries IPO
Anchor Investor Reservation7,32,000 shares0 shares
Market Maker Reservation1,38,000 shares81,600 shares
QIB5,40,000 shares0 shares
NII3,90,000 shares7,75,200 shares
RII9,00,000 shares7,75,200 shares
Employee0 shares0 shares
Others
Total25,62,000 shares15,50,400 shares

Bids Received (Subscription)

Goldline Pharmaceutical IPO subscribed 600.53x in total, whereas Jivial Industries IPO subscribed 0.93x.

 Goldline Pharmaceutical IPOJivial Industries IPO
QIB (times)180.22x
NII (times)1,662.04x1.57x
Big NII (times)2,010.60x
Small NII (times)980.75x
RII (times)881.15x0.22x
Employee (times)
Other (times)
Total (times)600.53x0.93x

Compare with others

Goldline Pharmaceutical IPOJivial Industries IPO
Adisoft Technologies IPOFractal Industries IPO
Madhur Knit IPOTrimoorty Foamtech IPO
Fractal Industries IPOK.V.Toys India IPO
Trimoorty Foamtech IPOGoldline Pharmaceutical IPO
K.V.Toys India IPODatasol IPO
Datasol IPOVK Tyre IPO
Jivial Industries IPOMopshop Distribution IPO
VK Tyre IPOHighness Microelectronics IPO
Mopshop Distribution IPORaksan Transformers IPO
Highness Microelectronics IPOEmiac Technologies IPO

Compare:

Goldline Pharmaceutical IPO Vs Jivial Industries IPO